Aclaris Therapeutics Announces Divestiture of RHOFADE®
Go back to Aclaris Therapeutics Announces Divestiture of RHOFADE®| (NASDAQ: ACRS) | Delayed: 5.97 -0.08 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.05 | 52 Week High | $33.88 | |||
| Open | $6.09 | 52 Week Low | $14.12 | |||
| Day High | $6.24 | P/E | N/A | |||
| Day Low | $5.95 | EPS | $0.00 | |||
| Volume | 678,455 | |||||

